US 7507740
Fused heterocyclic compound
granted A61PA61P1/18A61P11/00
Quick answer
US patent 7507740 (Fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/18, A61P11/00, A61P13/08, A61P13/12